What is Sihuan Pharmaceutical Holdings Group Median PS Value?
Sihuan Pharmaceutical Holdings GroupSHPHF 52 Median PS Value is $0.21 as of Jun. 25, 2026, which is 67% below its 10-year median of 0.63. GuruFocus rates SHPHF with a GF Score™ of 52/100 and a GF Value™ of $0.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 544 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks better than 71.87% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
SHPHF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.42 Med: 0.63 Max: 0.85
Current: 0.62
During the past 13 years, the highest Price to Median PS Value of Sihuan Pharmaceutical Holdings Group was 0.85. The lowest was 0.42. And the median was 0.63.
SHPHF's Price-to-Median-PS-Value is ranked better than 71.87% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.85
vs SHPHF: 0.62
Sihuan Pharmaceutical Holdings Group (OTCPK:SHPHF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Sihuan Pharmaceutical Holdings Group's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.1297
/
0.21
=
0.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group Median PS Value Related Terms
Sihuan Pharmaceutical Holdings Group Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group Median PS Value Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sihuan Pharmaceutical Holdings Group Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Price-to-Median-PS-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group (SHPHF) has a Median PS Value of $0.21 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is 67% below median its historical median of 0.63. Over the past decade, Sihuan Pharmaceutical Holdings Group's Median PS Value has ranged from 0.42 to 0.85. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #153 out of 544 companies in the Drug Manufacturers industry, placing it in the top 28.1%.
Is Sihuan Pharmaceutical Holdings Group's Median PS Value too high?
Sihuan Pharmaceutical Holdings Group's current Median PS Value of $0.21 is 67% below median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 0.85. The Drug Manufacturers industry median Median PS Value is 0.85. Sihuan Pharmaceutical Holdings Group's value of $0.21 is 75.3% below this industry median. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #153 out of 544 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's Median PS Value compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #153 out of 544 companies for Median PS Value. This puts Sihuan Pharmaceutical Holdings Group in the upper half of its industry. The industry median Median PS Value is 0.85. Sihuan Pharmaceutical Holdings Group's value of $0.21 is 75.3% below this benchmark. Historically, Sihuan Pharmaceutical Holdings Group's own Median PS Value has ranged from 0.42 to 0.85 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 0.85, Sihuan Pharmaceutical Holdings Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.85, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sihuan Pharmaceutical Holdings Group's current Median PS Value of $0.21 is 75.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sihuan Pharmaceutical Holdings Group's current Median PS Value is $0.21, which is 67% below median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.17, compared to a current price of $0.13 — trading 23.7% below its estimated fair value. The current Median PS Value is $0.21, which is 67% below median its 10-year median of 0.63 and 75.3% below the Drug Manufacturers industry median of 0.85. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Median PS Value is $0.21 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued.
The current stock price of $0.13 is trading 23.7% below its estimated GF Value™ of $0.17.
GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.
Key valuation signals for SHPHF:
Median PS Value: $0.21 (67% below median its 10-year median of 0.63)
GF Value™: $0.17 vs. price of $0.13 (23.7% below fair value)
Industry Position: 75.3% below the Drug Manufacturers median (#153 of 544)
No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sihuan Pharmaceutical Holdings Group Business Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
52GF Score
Get the complete analysis for SHPHF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPHF has been successfully added to your 
